Compounding Pharmacies Market Report
RA00436
Compounding Pharmacies Market, by Application (Children, Adult, Geriatric, Veterinary), Distribution Channel (Hospital Pharmacy, Compounding Pharmacies, Others), Therapeutic Area (Hormone Replacement, Pain Management, Dermatology applications, Specialty drugs, Nutritional supplements, Others), Sterility (Sterile Dosage Form, Non-Sterile Dosage Forms), By Compounding Type (Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA), Others): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global compounding pharmacies market is estimated to surpass $15,256.2 million by 2027, exhibiting a CAGR of 6.1% from 2020 to 2027.
OFFERINGS OF THE REPORT:
The report offers comprehensive analysis of the global compounding pharmacies market by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market.
The report also sheds light on present scenario and upcoming trends and developments that are contributing in the growth of the market. In addition, key market boomers and opportunities driving the market growth are provided in the report. Besides, restraints and challenges that hold power to obstruct the market growth are also profiled in the report. The report also offers Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and emergence of substitutes in the market.
Based on the key forces molding the market, the report offers future perspective and growth outlook of the global market. The report offers market size and forecast by keenly evaluating every segment of the global compounding pharmacies market. Regional market breakdown of these segments is also offered in the report. The report divides the global compounding pharmacies market into four main regions including Europe, North America, Asia-Pacific, and LAMEA. Furthermore, these regions are sub-divided to profile detailed panorama of the compounding pharmacies market across major countries in specific regions. Moreover, the report reveals some of the recent developments, trends, and forthcoming opportunities in every region.
HIGHLIGHTS OF THE MARKET
- The report offers market size and forecast for the period from 2019 to 2027
- This report highlights trends, innovations, and new developments along with a detailed quantitative analysis of the compounding pharmacies market during the period of forecast
- The prevailing and upcoming opportunities along with the tactical assessment of the global compounding pharmacies market growth is provided
- The market size and estimations are based on a comprehensive analysis of market drivers and restraints and key innovations in the compounding pharmacies market
- Information on leading market players, Porter’s Five Analysis, and top winning business strategies is offered
- The development plans and initiatives undertaken by the top market players are highlighted to understand the competitive landscape of the market
KEY MARKET SEGMENTS
The report segments the global market into application ,distribution channel ,therapeutic area ,sterility ,bu compounding type
- Application: Children, Adult, Geriatric, Veterinary
- Distribution Channel: Hospital Pharmacy, Compounding Pharmacies, Others
- Therapeutic Area: Hormone Replacement, Pain Management, Dermatology applications, Specialty drugs, Nutritional supplements, Others
- Sterility: Sterile Dosage Form, Non-Sterile Dosage Forms
- Bu Compounding Type: Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA), Others
Region:
The global compounding pharmacies market is divided into North America, Europe, Asia Pacific, and LAMEA.
The above-mentioned regions are further dived in countries as follows:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
LEADING PLAYERS OF THE MARKET
The most influential companies are mentioned in the report which include Lorraine
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Compounding Pharmacies Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Compounding Pharmacies Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Compounding Pharmacies Market, By Application
5.1. Overview
5.2 Children
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Adult
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Geriatric
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Veterinary
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Research Dive Exclusive Insights
5.6.1 Market attractiveness
5.6.2 Competition heatmap
-
6. Compounding Pharmacies Market, By Distribution Channel
6.1. Overview
6.2 Hospital Pharmacy
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Compounding Pharmacies
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Others
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Research Dive Exclusive Insights
6.5.1 Market attractiveness
6.5.2 Competition heatmap
-
7. Compounding Pharmacies Market, By Therapeutic Area
7.1. Overview
7.2 Hormone Replacement
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Pain Management
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Dermatology applications
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Specialty drugs
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 Nutritional supplements
7.6.1 Definition, key trends, growth factors, and opportunities
7.6.2 Market size analysis, by region, 2020-2027
7.6.3 Market share analysis, by country, 2020-2027
7.7 Others
7.7.1 Definition, key trends, growth factors, and opportunities
7.7.2 Market size analysis, by region, 2020-2027
7.7.3 Market share analysis, by country, 2020-2027
7.8 Research Dive Exclusive Insights
7.8.1 Market attractiveness
7.8.2 Competition heatmap
-
8. Compounding Pharmacies Market, By Sterility
8.1. Overview
8.2 Sterile Dosage Form
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Non-Sterile Dosage Forms
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Research Dive Exclusive Insights
8.4.1 Market attractiveness
8.4.2 Competition heatmap
-
9. Compounding Pharmacies Market, By Compounding Type
9.1. Overview
9.2 Pharmaceutical Ingredient Alteration (PIA)
9.2.1 Definition, key trends, growth factors, and opportunities
9.2.2 Market size analysis, by region, 2020-2027
9.2.3 Market share analysis, by country, 2020-2027
9.3 Currently Unavailable Pharmaceutical Manufacturing (CUPM)
9.3.1 Definition, key trends, growth factors, and opportunities
9.3.2 Market size analysis, by region, 2020-2027
9.3.3 Market share analysis, by country, 2020-2027
9.4 Pharmaceutical Dosage Alteration (PDA)
9.4.1 Definition, key trends, growth factors, and opportunities
9.4.2 Market size analysis, by region, 2020-2027
9.4.3 Market share analysis, by country, 2020-2027
9.5 Others
9.5.1 Definition, key trends, growth factors, and opportunities
9.5.2 Market size analysis, by region, 2020-2027
9.5.3 Market share analysis, by country, 2020-2027
9.6 Research Dive Exclusive Insights
9.6.1 Market attractiveness
9.6.2 Competition heatmap
10. Compounding Pharmacies Market, By Region
10.1 North America
10.1.1 U.S
10.1.1.1 Market size analysis, By Application, 2020-2027
10.1.1.2 Market size analysis, By Distribution Channel, 2020-2027
10.1.1.3 Market size analysis, By Therapeutic Area, 2020-2027
10.1.1.4 Market size analysis, By Sterility, 2020-2027
10.1.1.5 Market size analysis, By Compounding Type, 2020-2027
10.1.2 Canada
10.1.2.1 Market size analysis, By Application, 2020-2027
10.1.2.2 Market size analysis, By Distribution Channel, 2020-2027
10.1.2.3 Market size analysis, By Therapeutic Area, 2020-2027
10.1.2.4 Market size analysis, By Sterility, 2020-2027
10.1.2.5 Market size analysis, By Compounding Type, 2020-2027
10.1.3 Mexico
10.1.3.1 Market size analysis, By Application, 2020-2027
10.1.3.2 Market size analysis, By Distribution Channel, 2020-2027
10.1.3.3 Market size analysis, By Therapeutic Area, 2020-2027
10.1.3.4 Market size analysis, By Sterility, 2020-2027
10.1.3.5 Market size analysis, By Compounding Type, 2020-2027
10.1.4 Research Dive Exclusive Insights
10.1.4.1 Market attractiveness
10.1.4.2 Competition heatmap
10.2 Europe
10.2.1 Germany
10.2.1.1 Market size analysis, By Application, 2020-2027
10.2.1.2 Market size analysis, By Distribution Channel, 2020-2027
10.2.1.3 Market size analysis, By Therapeutic Area, 2020-2027
10.2.1.4 Market size analysis, By Sterility, 2020-2027
10.2.1.5 Market size analysis, By Compounding Type, 2020-2027
10.2.2 UK
10.2.2.1 Market size analysis, By Application, 2020-2027
10.2.2.2 Market size analysis, By Distribution Channel, 2020-2027
10.2.2.3 Market size analysis, By Therapeutic Area, 2020-2027
10.2.2.4 Market size analysis, By Sterility, 2020-2027
10.2.2.5 Market size analysis, By Compounding Type, 2020-2027
10.2.3 France
10.2.3.1 Market size analysis, By Application, 2020-2027
10.2.3.2 Market size analysis, By Distribution Channel, 2020-2027
10.2.3.3 Market size analysis, By Therapeutic Area, 2020-2027
10.2.3.4 Market size analysis, By Sterility, 2020-2027
10.2.3.5 Market size analysis, By Compounding Type, 2020-2027
10.2.4 Spain
10.2.4.1 Market size analysis, By Application, 2020-2027
10.2.4.2 Market size analysis, By Distribution Channel, 2020-2027
10.2.4.3 Market size analysis, By Therapeutic Area, 2020-2027
10.2.4.4 Market size analysis, By Sterility, 2020-2027
10.2.4.5 Market size analysis, By Compounding Type, 2020-2027
10.2.5 Italy
10.2.5.1 Market size analysis, By Application, 2020-2027
10.2.5.2 Market size analysis, By Distribution Channel, 2020-2027
10.2.5.3 Market size analysis, By Therapeutic Area, 2020-2027
10.2.5.4 Market size analysis, By Sterility, 2020-2027
10.2.5.5 Market size analysis, By Compounding Type, 2020-2027
10.2.6 Rest of Europe
10.2.6.1 Market size analysis, By Application, 2020-2027
10.2.6.2 Market size analysis, By Distribution Channel, 2020-2027
10.2.6.3 Market size analysis, By Therapeutic Area, 2020-2027
10.2.6.4 Market size analysis, By Sterility, 2020-2027
10.2.6.5 Market size analysis, By Compounding Type, 2020-2027
10.2.7 Research Dive Exclusive Insights
10.2.7.1 Market attractiveness
10.2.7.2 Competition heatmap
10.3 Asia-Pacific
10.3.1 China
10.3.1.1 Market size analysis, By Application, 2020-2027
10.3.1.2 Market size analysis, By Distribution Channel, 2020-2027
10.3.1.3 Market size analysis, By Therapeutic Area, 2020-2027
10.3.1.4 Market size analysis, By Sterility, 2020-2027
10.3.1.5 Market size analysis, By Compounding Type, 2020-2027
10.3.2 Japan
10.3.2.1 Market size analysis, By Application, 2020-2027
10.3.2.2 Market size analysis, By Distribution Channel, 2020-2027
10.3.2.3 Market size analysis, By Therapeutic Area, 2020-2027
10.3.2.4 Market size analysis, By Sterility, 2020-2027
10.3.2.5 Market size analysis, By Compounding Type, 2020-2027
10.3.3 India
10.3.3.1 Market size analysis, By Application, 2020-2027
10.3.3.2 Market size analysis, By Distribution Channel, 2020-2027
10.3.3.3 Market size analysis, By Therapeutic Area, 2020-2027
10.3.3.4 Market size analysis, By Sterility, 2020-2027
10.3.3.5 Market size analysis, By Compounding Type, 2020-2027
10.3.4 Australia
10.3.4.1 Market size analysis, By Application, 2020-2027
10.3.4.2 Market size analysis, By Distribution Channel, 2020-2027
10.3.4.3 Market size analysis, By Therapeutic Area, 2020-2027
10.3.4.4 Market size analysis, By Sterility, 2020-2027
10.3.4.5 Market size analysis, By Compounding Type, 2020-2027
10.3.5 South Korea
10.3.5.1 Market size analysis, By Application, 2020-2027
10.3.5.2 Market size analysis, By Distribution Channel, 2020-2027
10.3.5.3 Market size analysis, By Therapeutic Area, 2020-2027
10.3.5.4 Market size analysis, By Sterility, 2020-2027
10.3.5.5 Market size analysis, By Compounding Type, 2020-2027
10.3.6 Rest of Asia-Pacific
10.3.6.1 Market size analysis, By Application, 2020-2027
10.3.6.2 Market size analysis, By Distribution Channel, 2020-2027
10.3.6.3 Market size analysis, By Therapeutic Area, 2020-2027
10.3.6.4 Market size analysis, By Sterility, 2020-2027
10.3.6.5 Market size analysis, By Compounding Type, 2020-2027
10.3.7 Research Dive Exclusive Insights
10.3.7.1 Market attractiveness
10.3.7.2 Competition heatmap
10.4 LAMEA
10.4.1 Brazil
10.4.1.1 Market size analysis, By Application, 2020-2027
10.4.1.2 Market size analysis, By Distribution Channel, 2020-2027
10.4.1.3 Market size analysis, By Therapeutic Area, 2020-2027
10.4.1.4 Market size analysis, By Sterility, 2020-2027
10.4.1.5 Market size analysis, By Compounding Type, 2020-2027
10.4.2 Saudi Arabia
10.4.2.1 Market size analysis, By Application, 2020-2027
10.4.2.2 Market size analysis, By Distribution Channel, 2020-2027
10.4.2.3 Market size analysis, By Therapeutic Area, 2020-2027
10.4.2.4 Market size analysis, By Sterility, 2020-2027
10.4.2.5 Market size analysis, By Compounding Type, 2020-2027
10.4.3 UAE
10.4.3.1 Market size analysis, By Application, 2020-2027
10.4.3.2 Market size analysis, By Distribution Channel, 2020-2027
10.4.3.3 Market size analysis, By Therapeutic Area, 2020-2027
10.4.3.4 Market size analysis, By Sterility, 2020-2027
10.4.3.5 Market size analysis, By Compounding Type, 2020-2027
10.4.4 South Africa
10.4.4.1 Market size analysis, By Application, 2020-2027
10.4.4.2 Market size analysis, By Distribution Channel, 2020-2027
10.4.4.3 Market size analysis, By Therapeutic Area, 2020-2027
10.4.4.4 Market size analysis, By Sterility, 2020-2027
10.4.4.5 Market size analysis, By Compounding Type, 2020-2027
10.4.5 Rest of LAMEA
10.4.5.1 Market size analysis, By Application, 2020-2027
10.4.5.2 Market size analysis, By Distribution Channel, 2020-2027
10.4.5.3 Market size analysis, By Therapeutic Area, 2020-2027
10.4.5.4 Market size analysis, By Sterility, 2020-2027
10.4.5.5 Market size analysis, By Compounding Type, 2020-2027
10.4.6 Research Dive Exclusive Insights
10.4.6.1 Market attractiveness
10.4.6.2 Competition heatmap
11. Competitive Landscape
11.1 Top winning strategies, 2020-2027
11.1.1 By strategy
11.1.2 By year
11.2 Strategic overview
11.3 Market share analysis, 2020-2027
12. Company Profiles
12.1 B. Braun Medical
12.1.1 Overview
12.1.2 Business segments
12.1.3 Product portfolio
12.1.4 Financial performance
12.1.5 Recent developments
12.1.6 SWOT analysis
12.2 Dougherty's Pharmacy
12.2.1 Overview
12.2.2 Business segments
12.2.3 Product portfolio
12.2.4 Financial performance
12.2.5 Recent developments
12.2.6 SWOT analysis
12.3 Fagron
12.3.1 Overview
12.3.2 Business segments
12.3.3 Product portfolio
12.3.4 Financial performance
12.3.5 Recent developments
12.3.6 SWOT analysis
12.4 Fresenius Kabi
12.4.1 Overview
12.4.2 Business segments
12.4.3 Product portfolio
12.4.4 Financial performance
12.4.5 Recent developments
12.4.6 SWOT analysis
12.5 Institutional Pharmacy Solutions
12.5.1 Overview
12.5.2 Business segments
12.5.3 Product portfolio
12.5.4 Financial performance
12.5.5 Recent developments
12.5.6 SWOT analysis
12.6 Clinigen Group PLC
12.6.1 Overview
12.6.2 Business segments
12.6.3 Product portfolio
12.6.4 Financial performance
12.6.5 Recent developments
12.6.6 SWOT analysis
12.7 Lorraine’s Pharmacy
12.7.1 Overview
12.7.2 Business segments
12.7.3 Product portfolio
12.7.4 Financial performance
12.7.5 Recent developments
12.7.6 SWOT analysis
12.8 McGuff Company
12.8.1 Overview
12.8.2 Business segments
12.8.3 Product portfolio
12.8.4 Financial performance
12.8.5 Recent developments
12.8.6 SWOT analysis
12.9 Pencol Compounding Pharmacy
12.9.1 Overview
12.9.2 Business segments
12.9.3 Product portfolio
12.9.4 Financial performance
12.9.5 Recent developments
12.9.6 SWOT analysis
12.10 Athenex Pharma Solutions (Athenex Inc.)
12.10.1 Overview
12.10.2 Business segments
12.10.3 Product portfolio
12.10.4 Financial performance
12.10.5 Recent developments
12.10.6 SWOT analysis
12.11 Rx3 Compounding Pharmacy
12.11.1 Overview
12.11.2 Business segments
12.11.3 Product portfolio
12.11.4 Financial performance
12.11.5 Recent developments
12.11.6 SWOT analysis
12.12 Triangle Compounding Pharmacies
12.12.1 Overview
12.12.2 Business segments
12.12.3 Product portfolio
12.12.4 Financial performance
12.12.5 Recent developments
12.12.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
